Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma. - Wikidata - wikimedia - TriplyDB

Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma.

Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma.

http://www.wikidata.org/entity/Q37660323

about

Proteomics and peptidomics: moving toward precision medicine in urological malignancies Serum and urine biomarkers for human renal cell carcinoma Integrative analysis to select cancer candidate biomarkers to targeted validation.Analysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma.AHNAK2 is a potential prognostic biomarker in patients with PDAC.Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.The fascinating story of urine examination: From uroscopy to the era of microscopy and beyond.Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma Proteotranscriptomic Analysis Reveals Stage Specific Changes in the Molecular Landscape of Clear-Cell Renal Cell Carcinoma.PGRMC1 Is a Novel Potential Tumor Biomarker of Human Renal Cell Carcinoma Based on Quantitative Proteomic and Integrative Biological Assessments Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer.Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma.Englerin A induces an acute inflammatory response and reveals lipid metabolism and ER stress as targetable vulnerabilities in renal cell carcinoma The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification.Reduced cytosolic carboxypeptidase 6 (CCP6) level leads to accumulation of serum polyglutamylated DNAJC7 protein: A potential biomarker for renal cell carcinoma early detection.Comparative proteomic profiling identifies potential prognostic factors for human clear cell renal cell carcinoma.Downregulation of HSP60 disrupts mitochondrial proteostasis to promote tumorigenesis and progression in clear cell renal cell carcinoma Serum Proteome Alterations in Patients with Cognitive Impairment after Traumatic Brain Injury Revealed by iTRAQ-Based Quantitative Proteomics.Prediction and diagnosis of renal cell carcinoma using nuclear magnetic resonance-based serum metabolomics and self-organizing maps MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A.Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development.Quantitative proteomic analysis of formalin-fixed, paraffin-embedded clear cell renal cell carcinoma tissue using stable isotopic dimethylation of primary amines.Identification of CALM as the potential serum biomarker for predicting the recurrence of nasopharyngeal carcinoma using a mass spectrometry-based comparative proteomic approach.The proteomic landscape of renal tumors.Liquid biopsy: a step forward towards precision medicine in urologic malignancies.Prognostic significance of two lipid metabolism enzymes, HADHA and ACAT2, in clear cell renal cell carcinoma.Urinary metabolites in patients undergoing coronary catheterization via the radial versus femoral artery approach.Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.Label-free quantitative proteomic analysis reveals potential biomarkers and pathways in renal cell carcinoma.Proteome profiling of clear cell renal cell carcinoma in von Hippel-Lindau patients highlights upregulation of Xaa-Pro aminopeptidase-1, an anti-proliferative and anti-migratory exoprotease.A versatile reversed phase-strong cation exchange-reversed phase (RP-SCX-RP) multidimensional liquid chromatography platform for qualitative and quantitative shotgun proteomics.G6PD promotes renal cell carcinoma proliferation through positive feedback regulation of p-STAT3.Integrative analysis and machine learning on cancer genomics data using the Cancer Systems Biology Database (CancerSysDB).

P2860

Q26749401-00A2C00B-3C40-40E2-9DCC-6ACAC5E37B28 Q28084949-C87084A3-132E-445E-B5E3-283D0FDE6200 Q30278389-B79D86E9-91B7-4AB5-BFEF-67694BE6C012 Q30928926-A93D5082-9C8D-42EE-A53C-E5CD31E5B2E1 Q33761904-40850DB8-A31C-4C34-952A-AE1BD9A5BFFB Q34450277-B767335F-4431-4308-8BD6-A50E1D40B6DD Q35782652-6DFD281A-90A2-4C0F-9BA7-306779136741 Q35955319-7B10C5BF-D2E7-4CDF-B81E-21BED2DC6A7F Q36003500-A2B2AC2F-852A-456A-8888-56F4611FDA5A Q36255955-D031EEA0-CFF2-4D7E-9AD2-ABDFBAABB51B Q36260554-E2494E7F-83C2-42C7-90D1-9CD476D53B3F Q36299355-39BE61C4-912B-4931-A7CB-FB7A325E68B6 Q36308931-1E5F8041-AFE5-4616-8855-9F2EB29DF834 Q36605807-64D6E4E9-E62C-4C43-8540-A048F749E8DA Q36771005-5BCD2AAE-CF8E-480F-81A2-AD3C3ED11465 Q37225556-EF726575-1B67-417C-9C83-53A2B56E4449 Q37419277-B35E19C9-F2B6-40CC-94E9-BFCC63D0BC22 Q37437672-E2B96F9D-0F8A-43F5-A7FC-CBD6C03D6B9E Q37637793-3E9C6C07-C899-492E-B077-2320927AD268 Q37644836-BD35960D-C1EB-4368-9A34-969CF060F206 Q37688151-A651A770-B3A5-4F1D-B435-F5C4811E072E Q37714579-45F67103-40B8-4929-8BDC-837533578BEE Q38385203-A01504DD-4250-4FE3-B48C-41AEA2EFD6FC Q38604563-7FDE4FB6-E76A-4819-B086-A1CBF90629B0 Q38803559-C0AC4E92-6504-4F8C-B018-D595704F9501 Q39243268-41C30509-5D7D-483E-879A-D1CA832A3EF6 Q40160539-2C7AB653-46C4-4FC6-AA22-8C70015E1AF7 Q41656592-DCA2E665-83D8-4D92-AD83-00C3438A295C Q41698566-AB6960EB-5D98-409E-AF92-939CBDA32FA9 Q45711994-C27665FD-0D39-4FEF-B87A-7659301E21D5 Q47097655-1BDD1FED-4E97-4C66-BA20-0431B9B8DCC9 Q48393196-6191B4DC-6DC5-4733-9D39-6BBD59029774 Q49702070-BCA37DD8-6AA7-49C2-861C-2A79D21B30B8 Q55055725-7D6E075B-CD7B-4594-B7E9-CCECE31CC406

P2860

Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma.

http://www.wikidata.org/entity/Q37660323

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Quantitative proteomic analysi ...... nesis of renal cell carcinoma.

@en

Quantitative proteomic analysi ...... nesis of renal cell carcinoma.

@nl

type

label

Quantitative proteomic analysi ...... nesis of renal cell carcinoma.

@en

Quantitative proteomic analysi ...... nesis of renal cell carcinoma.

@nl

prefLabel

Quantitative proteomic analysi ...... nesis of renal cell carcinoma.

@en

Quantitative proteomic analysi ...... nesis of renal cell carcinoma.

@nl

P1433

Q37660323-329F92A8-D29A-468A-9C4C-5168062BE070

P1476

Q37660323-EDD34BE4-E8CC-40C1-8320-CE8F6D3700C9

P2093

Q37660323-09911C87-41E7-4713-A5A8-C6451F614D8D

Q37660323-37BFDBA7-ABAF-4A15-A6B8-D2E0E4C6D39B

Q37660323-3891CDC4-B69A-43B2-9137-A22D66B947AD

Q37660323-4519B72F-5427-4321-96D8-C08BEEC76370

Q37660323-5EC0A171-68FD-4C58-AE6F-484B6D0D13EE

Q37660323-6CFB7E6A-4F31-436A-8FDE-FD52B54BF9C7

Q37660323-8BC8E24B-FB63-463A-83AC-EE17E37B7A31

Q37660323-A917D544-E408-499C-A34D-2506A20A952F

Q37660323-BDD5D91F-C6C7-41F4-BEC1-60B9D049A4E3

Q37660323-D1458FDE-3532-4B85-BE2F-F8259CBCC6CF

P2860

Q37660323-05969499-C991-4C52-A31D-0989DCCEF499

Q37660323-15098A37-2CC9-4219-A99F-7113EA7FDE1B

Q37660323-185E2632-A21E-486A-A034-B95F36BE1FEE

Q37660323-1B2D97AA-A9BB-4C4F-8D0D-C85C7B214C04

Q37660323-1F6B4A4B-98AA-49C6-9C73-55D6C32339CE

Q37660323-254DD23F-EFE0-4173-BF9D-23317F8A5CF8

Q37660323-25749668-26C7-4448-9859-A5D9248DB3BE

Q37660323-3795D45D-D4D3-4D47-BF38-8AFC688DF404

Q37660323-38B2594B-43D7-44B0-8B28-C56FB4391233

Q37660323-4AD01F60-B014-4AF1-BF3A-33806526C196

P304

Q37660323-477D6A49-81E4-4C19-AB28-A49F94E8CE47

P31

Q37660323-1E05BBC9-F8D1-488E-8301-66134F181631

P356

Q37660323-FA445D27-B4FF-4D33-9659-9625C9AF79C4

P407

Q37660323-41D56862-993C-4466-B966-E7592CE9E2FD

P433

Q37660323-10FFE947-A321-422E-8C96-C7582E264717

P478

Q37660323-D676D237-A6F9-4C97-82E5-D0A7298581C2

P577

Q37660323-5A617AD9-2DB3-4CD8-8A32-C264248C5D05

P5875

Q37660323-92B435A1-53A4-450F-BF4F-AC3263E37AC5

P698

Q37660323-8E3D311C-9E19-4B27-9757-591453A59B98

P921

Q37660323-7e47fb5f-4154-4169-8d81-c410ae36d9f2

Q37660323-B96DEA09-195D-4BCC-BE7D-2BD6C45A391B

P932

Q37660323-BAB32935-EB0B-4BA1-BD33-AD81EF949656

P356

ONCOTARGET.1529

P1433

P1476

Quantitative proteomic analysi ...... nesis of renal cell carcinoma.

@en

P2093

Alexander D Romaschin

http://www.w3.org/2001/XMLSchema#string

Georg A Bjarnason

http://www.w3.org/2001/XMLSchema#string

George M Yousef

http://www.w3.org/2001/XMLSchema#string

Jason Lee

http://www.w3.org/2001/XMLSchema#string

K W Michael Siu

http://www.w3.org/2001/XMLSchema#string

Kenneth Pace

http://www.w3.org/2001/XMLSchema#string

Leroi V Desouza

http://www.w3.org/2001/XMLSchema#string

Michael As Jewett

http://www.w3.org/2001/XMLSchema#string

Nicole M A White

http://www.w3.org/2001/XMLSchema#string

Olena Masui

http://www.w3.org/2001/XMLSchema#string

P2860

Pathway analysis of kidney cancer using proteomics and metabolic profiling

Metabolism of kidney cancer: from the lab to clinical practice

The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored

Cluster analysis and display of genome-wide expression patterns

Expression profiling of human renal carcinomas with functional taxonomic analysis.

Use of serological proteomic methods to find biomarkers associated with breast cancer

Renal cell carcinoma and normal kidney protein expression

Pyruvate kinase type M2 and its role in tumor growth and spreading

The epidemiology of renal cell carcinoma

Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry.

P304

506-518

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.1529

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260120682

http://www.w3.org/2001/XMLSchema#string

P698

24504108

http://www.w3.org/2001/XMLSchema#string

P921

P932

3964225

http://www.w3.org/2001/XMLSchema#string